[Is YAG laser iridotomy suitable for the prevention of glaucoma attacks?].
In a prospective clinical trial comprising 41 eyes with narrow-angle glaucoma, the patency of YAG laser iridotomy was checked using a rapidly-acting parasympatholytic drug. YAG laser iridotomy was performed after an acute attack of angle-closure glaucoma, in either the affected or the fellow eye. Tropicamide mydriasis had no effect on IOP either in the patient group or in the control group of ten normotensive eyes.